Dr. Kelly A. Gendall, MD

Dr. Gendall practices at Carespot Express Healthcare in Neptune Beach, Florida.

Dr. Gendall's NPI, 1942418579, was assigned on May 18, 2007. Dr. Gendall graduated from University of Otago School of Medicine in 2004. Dr. Gendall holds Florida license ME132441.

Dr. Gendall's primary practice is Carespot Express Healthcare, at 410 Atlantic Blvd, Neptune Beach, FL 32266. The practice phone is (904) 241-0117.

Dr. Gendall's primary practice is Carespot Express Healthcare in Neptune Beach, Florida. The medical group on file is CareSpot Express Healthcare. Dmand AI also links Dr. Gendall to 5 more medical groups and 1 group practice or clinic, each named with a free account. Dr. Gendall's employer is on file too: an urgent care center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gendall practices, 2 sites in all. Vendor and product names are available with a free account.

General practice is Dr. Gendall's primary specialty in the NPI Registry, under taxonomy code 208D00000X. Dmand AI has Dr. Gendall's licenses on file in 2 states: Florida and Virginia.

Dmand AI lists acute skin infection, ankle or foot injury, asthma, bursitis, chronic obstructive pulmonary disease (COPD), eyelid inflammation, itchy rashes and lower back pain among the conditions Dr. Gendall treats.

CMS data shows 635 Medicare services from Dr. Gendall across 9 procedure codes in 2024, for 393 Medicare patients. Medicare paid $32,856 for them. Every service was in an office.

CMS counts 393 Medicare patients who saw Dr. Gendall in 2024. The largest group is 65 to 74, with 205 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 3% are also on Medicaid. Their average risk score is 0.98, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gendall's median patient age at 40, with 57% women.

In 2024, Dr. Gendall wrote 652 Medicare Part D claims for 343 patients. 88% of them were for generic drugs. CMS names the drug for 288 of them, across 13 drugs with 11 or more claims each, at $2,086 in total drug cost. In 2023, CMS named 110 claims across 6 drugs.

Dr. Gendall accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 33 papers to Dr. Gendall, published from 2006 to 2007. The most frequent topics are Bulimia, Anorexia Nervosa and Feeding and Eating Disorders. Dr. Gendall has published most often in Int J Eat Disord. Dr. Gendall's most frequent co-authors are Walter H. Kaye, MD, Maria C. La Via and Guido Klaus Wilhelm Frank, MD.

CMS Open Payments shows 12 general payments to Dr. Gendall from 6 drug and device companies from 2023 to 2024. Food and beverage make up the largest share, 83% of the total. Eli Lilly and Company paid the most, $69.

Dr. Gendall graduated from University of Otago School of Medicine in 2004.

Dr. Gendall is in network with 4 carriers, including Excellus BlueCross BlueShield, Cigna and Molina. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.